Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
65 participants
INTERVENTIONAL
2011-02-28
2011-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Influence of Fluid Intake on Daily Biological Rhythm and Mental Performance in Healthy Young Adults
NCT05491122
Effect of Genetic Differences on Levels of Water Disinfection Byproducts in Blood After Showering
NCT00340535
Water and Coffee Intervention in Humans
NCT06165185
Effects of Chronic Energy Drink Consumption on Cardiometabolic Endpoints
NCT03840863
The Acute Effect of and Energy Drink vs. Water Consumption on MAP, HR, and Energy Metabolism
NCT06330649
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1= Intervention
1-Increased water intake regimen
Arm 1-Intervention
2= Control
2-Non-modified water intake regimen
Arm 2-Control
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
1-Increased water intake regimen
Arm 1-Intervention
2-Non-modified water intake regimen
Arm 2-Control
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Smoker with at least 15 cigarettes/day
* Subjects with body mass index between 18 and 27kg/m2 (bound included)
* Subjects with a 3-meal diet (breakfast, lunch, dinner)
* Subjects who have an easy daily access to internet
* Subjects able to communicate well with the investigator and willing to comply the requirement of the study
* Subjects who have signed the form of informed consent and are registered to the French national welfare system
Exclusion Criteria
* Subject practising physical activity in an intensive way according to the investigator judgment.
* Subject with a history of metabolic disease or with acute or chronic gastrointestinal disease except appendicectomy
* Subjects with diagnosed urinary tract disease
* Subjects with diagnosed lung or respiratory disease
* Subjects consuming regularly more than 3 units of alcohol per day
* Subjects who take drugs or presenting drug addiction (cannabis, opioids, amphetamines.)
* Subjects presenting a situation interfering with the outcomes of the study according to the investigator opinion
* Subjects working with painting, dry cleaning, dyes, pesticides, aluminium or alphalt
* Subjects who eat charcoaled food more than three meals/week
* Subjects with a vegetarian diet
* Subjects under local or general treatment which can modify measurements performed in the study, in particular the assessment of the hydration status (diuretic intake, or treatment interfering with metabolism and nutrition behaviour)
* Subjects planning to stop or reducing smoking or change their cigarette brand within the next 3 months
* Subjects in a situation which in the investigator's opinion could interfere with optimal participation in the present study or could constitute a special risk for the subject
* Subjects currently in a exclusion period following participation in another clinical trial
* Subjects having received 4500 euros indemnities for participation in clinical trials in the 12 previous months (including participation in the present study)
20 Years
45 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Danone Global Research & Innovation Center
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre CAP
Montpellier, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NU340
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.